EX-229

Modify Date: 2025-08-21 20:00:21

EX-229 Structure
EX-229 structure
Common Name EX-229
CAS Number 1219739-36-2 Molecular Weight 431.87
Density N/A Boiling Point N/A
Molecular Formula C24H18ClN3O3 Melting Point N/A
MSDS N/A Flash Point N/A

 Use of EX-229


EX229, a Benzimidazole derivative, is a potent and allosteric activator of AMP-activated protein kinase (AMPK), with Kds of 0.06 μM, 0.06 μM and 0.51 μM for α1β1γ1, α2β1γ1 and α1β2γ1 in biolayer interferometry, respectively.

 Names

Name EX229

 EX-229 Biological Activity

Description EX229, a Benzimidazole derivative, is a potent and allosteric activator of AMP-activated protein kinase (AMPK), with Kds of 0.06 μM, 0.06 μM and 0.51 μM for α1β1γ1, α2β1γ1 and α1β2γ1 in biolayer interferometry, respectively.
Related Catalog
Target

AMPK α1β1γ1:0.06 μM (Kd)

AMPK α2β1γ1:0.06 μM (Kd)

AMPK α1β2γ1:0.51 μM (Kd)

In Vitro EX229 is a potent and allosteric activator of AMP-activated protein kinase (AMPK), with Kds of 0.06 μM, 0.06 μM and 0.51 μM for α1β1γ1, α2β1γ1 and α1β2γ1, respectively.[1]. Treatment of hepatocytes with EX229 (991) alone results in a slight increase in the phosphorylation of AMPK and RAPTOR only at 0.3 μM, whereas a robust increase in ACC phosphorylation is readily observed and saturated at a concentration of 0.03 μM EX229. AICAR or C13 alone robustly increases T172 phosphorylation of AMPKα, and when 991 is coincubated, there is a modest additional dose-dependent increase in AMPKα phosphorylation. RAPTOR phosphorylation is modestly increased by AICAR or C13 alone, and it is dose dependently increased when coincubations are carried out with EX229. EX229 also dose dependently (0.01 and 0.1 μM) inhibits lipogenesis (34% and 63%, respectively), which is further reduced when it is coincubated with a low dose of AICAR (0.03 mM) or C13 (1 μM). Treatment with EX229 promotes dose-dependent increases in ACC and RAPTOR phosphorylation. Similar to the observations in hepatocytes[2].
References

[1]. Xiao B, et al. Structural basis of AMPK regulation by small molecule activators. Nat Commun. 2013;4:3017.

[2]. Bultot L, et al. Benzimidazole derivative small-molecule 991 enhances AMPK activity and glucose uptake induced by AICAR or contraction in skeletal muscle. Am J Physiol Endocrinol Metab. 2016 Oct 1;311(4):E706-E719.

 Chemical & Physical Properties

Molecular Formula C24H18ClN3O3
Molecular Weight 431.87
InChIKey FHWSAZXFPUMKFL-UHFFFAOYSA-N
SMILES Cc1ccc(Oc2nc3cc(-c4ccc5c(ccn5C)c4)c(Cl)cc3[nH]2)cc1C(=O)O
Storage condition -20℃
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.
Top Suppliers:I want be here



Get all suppliers and price by the below link:

EX-229 suppliers


Price: ¥3080/10 mM * 1 mL in DMSO

Reference only. check more EX-229 price

Related Compounds: More...
2-[2-[(Z)-(5-methoxy-6-oxocyclohexa-2,4-dien-1-ylidene)methyl]hydrazinyl]-N-(4-methoxyphenyl)-2-oxoacetamide
5530-49-4
3-[(2R,6S)-2,6-dimethylmorpholin-4-yl]-2-methyl-1-[4-(2-methylbutan-2-yl)phenyl]propan-1-one,hydrochloride
1260498-35-8
EX-527 R-enantiomer
848193-69-1
EX-527 (S-enantiomer)
848193-68-0
Ex26
1233332-37-0
6-chloro-1,1-dioxo-3-[(2E)-2-(phthalazin-1-ylhydrazinylidene)propyl]-3,4-dihydro-2H-1λ6,2,4-benzothiadiazine-7-sulfonamide
88-36-8
(6E)-4-cyclohexyl-6-[[4-[1-[4-[(2E)-2-(3-cyclohexyl-6-oxocyclohexa-2,4-dien-1-ylidene)hydrazinyl]-3-methylphenyl]cyclohexyl]-2-methylphenyl]hydrazinylidene]cyclohexa-2,4-dien-1-one
6706-82-7
2-[[5-chloro-4-[2-chloro-4-[[1-(2,4-dimethylanilino)-1,3-dioxobutan-2-yl]diazenyl]-5-methoxyphenyl]-2-methoxyphenyl]diazenyl]-N-(2,4-dimethylphenyl)-3-oxobutanamide
6528-35-4
tetrasodium,(3E)-3-[[4-[(2E)-2-[6-[[(6Z)-6-[[4-[(2Z)-2-(3-carboxylato-4-oxocyclohexa-2,5-dien-1-ylidene)hydrazinyl]-2-methoxy-5-methylphenyl]hydrazinylidene]-5-oxo-7-sulfonatonaphthalen-2-yl]amino]-1-oxo-3-sulfonatonaphthalen-2-ylidene]hydrazinyl]-5-metho
6535-56-4
8,8-Dimethyl-2,12-dioxa-5-azadispiro[3.1.5^{6}.3^{4}]tetradecane
2168397-22-4
4-ethyl-3-(4-methyl-4H-1,2,4-triazol-3-yl)cyclohexan-1-one
2138102-29-9
4-ethyl-3-(2-methyl-2H-1,2,3,4-tetrazol-5-yl)cyclohexan-1-one
2138064-82-9
4-Ethyl-3-(2-methyl-1,3-thiazol-5-yl)cyclohexan-1-one
2138527-09-8
4-Ethyl-3-(2-methylbutan-2-yl)cyclohexan-1-one
2138033-40-4
2-[3-(Benzyloxy)-1-hydroxycyclobutyl]propanoic acid
2143181-51-3
methyl (3S)-3-isocyanatobutanoate
2648902-08-1
[(2R,4aR,7aS)-2-methyl-6-(4-methylbenzenesulfonyl)-1H,2H,4aH,5H,6H,7H,7aH-pyrrolo[3,4-b]pyridin-7a-yl]methanol
1860810-34-9
[(2R,4aR,7aS)-2-methyl-6-(4-methylbenzenesulfonyl)-1H,2H,4aH,5H,6H,7H,7aH-pyrrolo[3,4-b]pyridin-7a-yl]methyl benzoate
1860810-35-0
1-[1-(2-Bromo-3-methoxyphenyl)cyclopropyl]ethan-1-one
2228166-19-4